financetom
Business
financetom
/
Business
/
Airtel completes acquisition of 4.7% stake in Indus Towers from Vodafone Group
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Airtel completes acquisition of 4.7% stake in Indus Towers from Vodafone Group
Mar 29, 2022 10:44 AM

Bharti Airtel along with its wholly-owned subsidiary has acquired about 4.7 percent stake in Indus Towers from Euro Pacific Securities, an affiliate of Vodafone Group, a stock exchange filing said on Tuesday. The shares were acquired at Rs 187.88 a piece, it said.

Share Market Live

NSE

"...We wish to submit that the company, along with its wholly-owned subsidiary, Nettle Infrastructure Investments Limited, has acquired 127,105,179 equity shares (about 4.7 percent) of Indus Towers at Rs 187.88 per share from Euro Pacific Securities Ltd., an affiliate of Vodafone Group Plc," Airtel said in a BSE filing.

Last week, Bharti Airtel had said it will acquire 4.7 percent stake in Indus Towers from Vodafone Group for about Rs 2,388 crore.

Indus Towers, formerly Bharti Infratel, provides passive telecom infrastructure. It owns, deploys and manages telecom towers and communication structures for various mobile phone service operators. The company's portfolio of over 1,84,748 telecom towers makes it one of the largest tower infrastructure providers in the country having presence in all 22 telecom circles.

Indus Towers caters to all wireless telecommunication service providers in India. On February 25, Bharti Airtel had informed that it has inked an agreement to buy Vodafone's 4.7 percent stake in Indus Towers on the condition that the proceeds will be used for investment in Vodafone Idea and clearing its dues towards the mobile tower company.

Also Read:

Analysts expect telecom companies to report a strong Q4FY22

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved